Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Stockholders' Equity, Beginning Balance, Amount at Dec. 31, 2024	$ 281,238	$ 40	$ 903,127	$ 166	$ (622,095)
Stockholders' Equity, Beginning Balance, Shares at Dec. 31, 2024		40,428,220
Shares issued for the exercise of stock options and vesting of restricted stock units, Amount	697	$ 1	696
Shares issued for the exercise of stock options and vesting of restricted stock units, Shares		210,332
Shares redeemed for employee tax withholdings, Amount	(1,418)		(1,418)
Shares redeemed for employee tax withholdings, Shares		(50,012)
Stock-based compensation expense	7,140		7,140
Unrealized loss on short-term investments and cash equivalents, net of tax	(157)			(157)
Foreign currency translation adjustment	6			6
Net Income (Loss)	(8,190)				(8,190)
Stockholders' Equity, Ending Balance, Amount at Mar. 31, 2025	279,316	$ 41	909,545	15	(630,285)
Stockholders' Equity, Ending Balance, Shares at Mar. 31, 2025		40,588,540
Stockholders' Equity, Beginning Balance, Amount at Dec. 31, 2025	$ 275,683	$ 41	936,628	53	(661,039)
Stockholders' Equity, Beginning Balance, Shares at Dec. 31, 2025	41,242,005	41,242,005
Shares issued for the exercise of stock options and vesting of restricted stock units, Amount	$ 144	$ 0	144
Shares issued for the exercise of stock options and vesting of restricted stock units, Shares		204,323
Shares redeemed for employee tax withholdings, Amount	(473)		(473)
Shares redeemed for employee tax withholdings, Shares		(62,208)
Stock-based compensation expense	7,945		7,945
Unrealized loss on short-term investments and cash equivalents, net of tax	(120)			(120)
Net Income (Loss)	(15,884)				(15,884)
Stockholders' Equity, Ending Balance, Amount at Mar. 31, 2026	$ 267,295	$ 41	$ 944,244	$ (67)	$ (676,923)
Stockholders' Equity, Ending Balance, Shares at Mar. 31, 2026	41,384,120	41,384,120